脂肪肝
医学
内科学
铁蛋白
2型糖尿病
糖尿病
胃肠病学
贫血
海西定
疾病
内分泌学
作者
Huanjia Qu,Lingling Zhou,Jing Wang,Dong Tang,Qiuling Zhang,Junping Shi
出处
期刊:Obesity
[Wiley]
日期:2025-02-06
卷期号:33 (3): 490-499
被引量:14
摘要
Abstract Objective The relationship between iron metabolism disturbances and metabolic dysfunction‐associated fatty liver disease (MAFLD) remains controversial. This study aimed to investigate the association of iron overload with MAFLD in patients with type 2 diabetes mellitus (T2DM). Methods This study included 155 Chinese inpatients with T2DM. MAFLD was diagnosed and grouped using magnetic resonance imaging (MRI). MRI biomarkers such as proton density fat fraction and iron accumulation () were measured. Their clinical characteristics were compared, and the association of iron metabolism markers with MAFLD in patients with T2DM was analyzed. Results Iron metabolism markers, including MRI‐, ferritin, serum iron, hepcidin, and total iron‐binding capacity, were overloaded in groups with MAFLD ( p < 0.001 for trend). They were positively correlated with MAFLD and reflected the severity of MAFLD. The five markers of logistic regression analysis revealed an increased MAFLD risk ( p < 0.001 for trend). The areas under the curve of five markers all exceeded 0.5, indicating certain predictive values for MAFLD. Conclusions MAFLD is associated with significant iron overload in Chinese patients with T2DM. Serum iron, ferritin, total iron‐binding capacity, hepcidin, and value are essential iron metabolism markers to evaluate and predict the progression of MAFLD in patients with T2DM.
科研通智能强力驱动
Strongly Powered by AbleSci AI